8-K: Brag House Secures $100M Equity Line, $11M Convertible Note

Brag House Holdings, Inc. and House of Doge Inc. have entered into new financing agreements, including a $100 million equity line of credit and an $11 million convertible promissory note, to bolster capital.

Summary

• Brag House Holdings, Inc. (Pubco) and House of Doge Inc. (HOD) secured a Common Stock Purchase Agreement (equity line of credit) with an institutional investor, allowing them to sell up to $100,000,000 in newly issued common stock over a 36-month period.
• The purchase price for shares under the equity line will be 97% of the volume-weighted average price (VWAP) on the purchase date, with options for intraday purchases.
• A $1,000,000 cash commitment fee was earned by the investor on December 4, 2025, payable as 10% of gross proceeds from equity line purchases until fully paid.
• The company also issued a Convertible Promissory Note for up to $11,000,000 to the same investor, with an initial advance of $3,850,000 (gross proceeds of $3,465,000) already received, with net proceeds directed to HOD.
• A second advance of $7,150,000 under the Convertible Note is contingent on conditions including the effectiveness of a registration statement, stockholder approval for share issuances exceeding the Nasdaq 19.99% cap, and the occurrence of the Business Combination Event.
• The Convertible Note carries a 0% interest rate, increasing to 15% upon an Event of Default, and is convertible at 95% of the lowest daily VWAP during the five preceding trading days.
• A 5.0% premium on the outstanding principal of the Convertible Note is payable if a 'BCA Delay' occurs (Business Combination not effective by February 13, 2026).
• The company's existing $8,000,000 loan to HOD (HOD Note) was amended to increase its principal to $10,000,000 and to subordinate Pubco's lien on HOD's obligations to the new investor's lien.
• A Pledge Agreement grants the investor a first-priority security interest in CleanCore Solutions, Inc. equity interests owned by Pubco and Dogecoin Ventures, Inc., including 4,000,000 Class B common stock from Pubco and 9,000,000 Class B common stock from Dogecoin, plus a warrant for 1,000,000 CleanCore shares.
• A Global Guaranty Agreement was executed by various subsidiaries of Brag House and HOD, guaranteeing the obligations under the new financing agreements.
• A Registration Rights Agreement commits the company to file a registration statement for the resale of the investor's shares by December 25, 2025, aiming for effectiveness by February 2, 2026.
• The issuance of shares under the equity line and convertible note is subject to a Nasdaq 19.99% cap (3,957,838 shares) unless stockholder approval is obtained, and an investor beneficial ownership limit of 4.99% (or 9.99% if increased by the investor).

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While the company secured significant capital access, the terms involve substantial dilution potential, commitment fees, and subordination of existing intercompany debt. The financing provides necessary liquidity and supports strategic initiatives but comes with notable costs and risks for existing shareholders.

Positives

• Secured access to significant capital: up to $100,000,000 through an equity line and up to $11,000,000 via a convertible note, providing substantial funding flexibility.
• The equity line allows the company to control the timing and amount of share sales, enabling strategic capital deployment based on market conditions.
• The Convertible Promissory Note has a 0% interest rate, reducing immediate debt servicing costs, unless an Event of Default occurs.
• The financing is structured to support the ongoing Business Combination with House of Doge Inc., indicating progress towards strategic objectives.

Negatives

• Significant potential for shareholder dilution due to the equity line of credit and the convertible note, especially if shares are sold at a discount to market prices (97% of VWAP for equity line, 95% of lowest 5-day VWAP for conversion).
• A $1,000,000 cash commitment fee is payable to the investor, reducing net proceeds from initial equity line purchases.
• Additional legal fees of $100,000 were reimbursed to the investor, plus up to $10,000 per fiscal quarter for ongoing due diligence, adding to transaction costs.
• The existing $8,000,000 loan from Pubco to HOD was increased to $10,000,000 and explicitly subordinated to the new investor's lien, weakening Pubco's position as a creditor to HOD.
• A 5.0% premium on the outstanding principal of the Convertible Note is triggered if the Business Combination is delayed beyond February 13, 2026, adding a penalty for delays.
• The 19.99% Nasdaq cap on share issuances without stockholder approval could limit immediate access to the full $100,000,000 equity line if the stock price is low, requiring further corporate action.
• The investor's beneficial ownership is capped at 4.99% (or 9.99% if increased), which could limit the investor's ability to fully convert or purchase shares if the company's stock price declines significantly, potentially leaving the company with less capital than desired.

Risks

• **Dilution Risk:** The issuance of up to $100,000,000 in common stock and the conversion of the $11,000,000 note could significantly dilute existing shareholders, especially if the stock price declines.
• **Market Price Risk:** The purchase price for equity line shares (97% of VWAP) and the conversion price for the note (95% of lowest 5-day VWAP) are tied to market prices, meaning the company will receive less capital per share if its stock price falls.
• **Business Combination Delay Risk:** A 5.0% premium on the convertible note's principal is triggered if the Business Combination is not effective by February 13, 2026, adding financial cost.
• **Regulatory Compliance Risk:** Failure to obtain stockholder approval for share issuances exceeding the Nasdaq 19.99% cap could limit the company's ability to draw on the full equity line.
• **Liquidity Risk:** The company's ability to draw on the equity line depends on market conditions and its stock price, which could impact its funding sources.
• **Subordination Risk:** Pubco's existing loan to HOD is now subordinated to the new investor's lien, increasing Pubco's risk exposure in HOD if HOD faces financial distress.
• **Event of Default Risk:** Various events, including failure to make payments, bankruptcy, significant judgments, delisting, or breaches of covenants, could trigger an Event of Default, leading to acceleration of the Convertible Note and potential enforcement of security interests.
• **CleanCore Collateral Risk:** The investor's first-priority lien on CleanCore Equity Interests means that in an Event of Default, the investor would have priority access to these assets, potentially impacting the company's strategic flexibility or value derived from CleanCore.

Future Outlook

The company intends to use the proceeds from these financing agreements to fund its business and operations, with actual sales of common shares under the equity line depending on market conditions and the trading price of its securities. The second advance of the convertible note is contingent on the successful completion of the Business Combination and stockholder approval for share issuances exceeding the Nasdaq cap, indicating a reliance on these future events for full funding.

Management Comments

• Management acknowledges that the issuance of securities could cause dilution to existing stockholders and significantly increase the number of outstanding common stock shares.
• Management confirms its obligation to issue shares under the equity line and convertible note is absolute and unconditional, regardless of dilutive effect.
• The company will control the timing and amount of any sales of its Common Shares to the Investor, depending on market conditions, trading price, and funding needs.

Industry Context

This financing structure, involving an equity line of credit and a convertible note, is a common method for smaller public companies, particularly those in growth phases or undergoing strategic transactions like mergers (e.g., the HOD Business Combination), to secure capital. The terms, including discounts to VWAP and commitment fees, reflect the risk profile often associated with such companies and the current market's appetite for these types of instruments. The subordination of existing intercompany debt (HOD to Pubco) to the new investor's lien is a standard requirement to enhance the security for the new capital provider, but it also highlights the financial interdependencies within the corporate structure.

Comparison to Industry Standards

• The 3% discount to VWAP for the equity line and 5% discount to the lowest 5-day VWAP for the convertible note conversion are within the typical range for such financing arrangements for small-cap companies, reflecting a balance between investor incentive and company cost of capital.
• The $1,000,000 commitment fee and legal expense reimbursements are customary for equity line facilities of this size, compensating the investor for their commitment and due diligence.
• The 0% interest rate on the convertible note (unless default) is favorable, but the 90% purchase price (10% discount) effectively acts as upfront interest or a structuring fee, which is also common in such notes.
• The 19.99% Nasdaq cap without shareholder approval is a standard regulatory constraint (Nasdaq Rule 5635(d)) to protect existing shareholders from excessive dilution without their consent, aligning with corporate governance best practices for public companies.
• The first-priority pledge of CleanCore Solutions, Inc. equity interests as collateral is a strong security measure for the investor, typical when a company's core assets or strategic investments are deemed valuable and liquid.

Corporate Governance

Related Party Transactions

• The company (Pubco) previously loaned HOD $8,000,000, evidenced by the HOD Note. This note was amended to increase the principal to $10,000,000 and to subordinate Pubco's lien to the new investor's lien. This is an intercompany transaction between Pubco and its subsidiary HOD, which is now subordinated to a third-party investor.

Stakeholder Impact

• **Shareholders:** Face significant potential dilution from the equity line and convertible note. The value of existing shares could decrease, especially if new shares are issued at a discount. However, the capital infusion could support growth and strategic initiatives, potentially benefiting shareholders long-term.
• **Employees:** The capital raise provides financial stability, which can positively impact job security and the company's ability to invest in its workforce and operations.
• **Creditors (Pubco as HOD's creditor):** Pubco's existing loan to HOD is now subordinated to the new investor's lien, increasing Pubco's risk exposure in HOD. This could impact Pubco's ability to recover its loan to HOD in a distress scenario.
• **New Investor:** Gains a first-priority security interest in valuable CleanCore equity, favorable conversion terms, and fees, positioning them advantageously in the company's capital structure.

Next Steps

• File an initial Registration Statement covering the resale of Registrable Securities by the Investor with the SEC by December 25, 2025.
• Use commercially reasonable efforts to cause the initial Registration Statement to be declared effective by the SEC by February 2, 2026.
• Obtain stockholder approval for the issuance of shares exceeding the Nasdaq 19.99% cap, if the company intends to utilize the full $100,000,000 equity line.
• Satisfy conditions for the second advance of $7,150,000 under the Convertible Promissory Note, including the effectiveness of the Registration Statement and the occurrence of the Business Combination Event.
• Complete the Business Combination Event by February 13, 2026, to avoid a 5.0% premium on the Convertible Note, and by March 31, 2026, to avoid an accelerated maturity date for the note.
• Commence monthly cash amortization payments on the Convertible Note starting February 1, 2026.

Key Dates

Recommendation

The company has secured significant financing, which is crucial for its operations and the pending Business Combination. This provides a necessary capital runway. However, the terms involve substantial potential dilution for existing shareholders, significant fees, and the subordination of intercompany debt. While the capital infusion is a positive for liquidity and strategic execution, the dilutive nature and associated costs warrant a 'hold' recommendation. Investors should monitor the company's execution of the Business Combination, the utilization of the equity line, and the impact on share price and outstanding share count before making further investment decisions.

Keywords

Equity Line of Credit, Convertible Note, Capital Raise, Dilution, SEC Filing, BRAG HOUSE HOLDINGS, HOUSE OF DOGE, CleanCore Solutions, Corporate Finance, Stock Purchase Agreement, Pledge Agreement, Subordination Agreement, Nasdaq Compliance